A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection

Neuron

Volumn 64, Issue 1, 2009, Pages 133-145

  Kraft Terry, Stephanie D ^a   Buch, Shilpa J ^a   Fox, Howard S ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE; CYTOKINE; GLATIRAMER; LITHIUM; MEMANTINE; MINOCYCLINE; NANOPARTICLE; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ADJUVANT CHEMOTHERAPY; AUTOPHAGY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG ABUSE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EXPERIMENTAL ANIMAL; GLIA CELL; HIV 1 ASSOCIATED NEUROCOGNITIVE DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION CONTROL; MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; NANOMEDICINE; NERVE DEGENERATION; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; VIRUS ENCEPHALITIS;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN; HIV INFECTIONS; HUMANS; MODELS, NEUROLOGICAL; NEUROGLIA; NEUROIMMUNOMODULATION; NEURONS;

EID: 70349810685     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.09.042     Document Type: Review

References (147)

1. Achim C.L., Adame A., Dumaop W., Everall I.P., and Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J. Neuroimmune Pharmacol. 4 (2009) 190-199
2. Aksenov M.Y., Aksenova M.V., Nath A., Ray P.D., Mactutus C.F., and Booze R.M. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27 (2006) 217-228
3. Alirezaei M., Kiosses W.B., Flynn C.T., Brady N.R., and Fox H.S. Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3 (2008) e2906
4. Alirezaei M., Kiosses W.B., and Fox H.S. Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4 (2008) 963-966
5. Anthony I.C., and Bell J.E. The Neuropathology of HIV/AIDS. Int. Rev. Psychiatry 20 (2008) 15-24
6. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., and Bell J.E. Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64 (2005) 529-536
7. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69 (2007) 1789-1799
8. Baldwin G.C., Tashkin D.P., Buckley D.M., Park A.N., Dubinett S.M., and Roth M.D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156 (1997) 1606-1613
9. Banerjee R., Mosley R.L., Reynolds A.D., Dhar A., Jackson-Lewis V., Gordon P.H., Przedborski S., and Gendelman H.E. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE 3 (2008) e2740
10. Bell J.E., Brettle R.P., Chiswick A., and Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121 (1998) 2043-2052
11. Benoit M., Desnues B., and Mege J.L. Macrophage polarization in bacterial infections. J. Immunol. 181 (2008) 3733-3739
12. Berry C.C., de la Fuente J.M., Mullin M., Chu S.W., and Curtis A.S. Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans. Nanobioscience 6 (2007) 262-269
13. Boisse L., Gill M.J., and Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol. Clin. 26 (2008) 799-819
14. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., Metivier D., Meley D., Souquere S., Yoshimori T., et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25 (2005) 1025-1040
15. Brabers N.A., and Nottet H.S. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur. J. Clin. Invest. 36 (2006) 447-458
16. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17 (2003) 1775-1788
17. Cao W., Jamieson B.D., Hultin L.E., Hultin P.M., and Detels R. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res. Hum. Retroviruses 25 (2009) 183-191
18. Cassol E., Cassetta L., Rizzi C., Alfano M., and Poli G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 182 (2009) 6237-6246
19. Chana G., Everall I.P., Crews L., Langford D., Adame A., Grant I., Cherner M., Lazzaretto D., Heaton R., Ellis R., and Masliah E. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67 (2006) 1486-1489
20. Chaudhuri A., Yang B., Gendelman H.E., Persidsky Y., and Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111 (2008) 2062-2072
21. Cheung R., Ravyn V., Wang L., Ptasznik A., and Collman R.G. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J. Immunol. 180 (2008) 6675-6684
22. Clements J.E., Li M., Gama L., Bullock B., Carruth L.M., Mankowski J.L., and Zink M.C. The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J. Neurovirol. 11 (2005) 180-189
23. Clements J.E., Mankowski J.L., Gama L., and Zink M.C. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J. Neurovirol. 14 (2008) 309-317
24. Clifford D.B., Smurzynski M., Park L.S., Yeh T.M., Zhao Y., Blair L., Arens M., and Evans S.R. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology 73 (2009) 309-314
25. Cornblath D.R., and Hoke A. Recent advances in HIV neuropathy. Curr. Opin. Neurol. 19 (2006) 446-450
26. Crews L., Lentz M.R., Gonzalez R.G., Fox H.S., and Masliah E. Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. J. Neurovirol. 14 (2008) 327-339
27. Crews L., Patrick C., Achim C.L., Everall I.P., and Masliah E. Molecular Pathology of Neuro-AIDS (CNS-HIV). Int. J. Mol. Sci. 10 (2009) 1045-1063
28. Cysique L.A., and Brew B.J. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol. Rev. 19 (2009) 169-185
29. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
30. Dhillon N.K., Williams R., Callen S., Zien C., Narayan O., and Buch S. Roles of MCP-1 in development of HIV-dementia. Front. Biosci. 13 (2008) 3913-3918
31. Donahoe R.M., O'Eil S.P., Marsteller F.A., Novembre F.J., Anderson D.C., Lankford-Turner P., and McClure H.H. Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model. J. Acquir. Immune Defic. Syndr. 50 (2009) 241-249
32. Dore G.J., McDonald A., Li Y., Kaldor J.M., and Brew B.J. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17 (2003) 1539-1545
33. Dou H., Kingsley J.D., Mosley R.L., Gelbard H.A., and Gendelman H.E. Neuroprotective strategies for HIV-1 associated dementia. Neurotox. Res. 6 (2004) 503-521
34. Dou H., Ellison B., Bradley J., Kasiyanov A., Poluektova L.Y., Xiong H., Maggirwar S., Dewhurst S., Gelbard H.A., and Gendelman H.E. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J. Neurosci. 25 (2005) 8375-8385
35. Dou H., Destache C.J., Morehead J.R., Mosley R.L., Boska M.D., Kingsley J., Gorantla S., Poluektova L., Nelson J.A., Chaubal M., et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108 (2006) 2827-2835
36. Dou H., Grotepas C.B., McMillan J.M., Destache C.J., Chaubal M., Werling J., Kipp J., Rabinow B., and Gendelman H.E. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J. Immunol. 183 (2009) 661-669
37. Ellis R., Langford D., and Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat. Rev. Neurosci. 8 (2007) 33-44
38. Erdmann N.B., Whitney N.P., and Zheng J. Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase. Clin. Neurosci. Res. 6 (2006) 315-328
39. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., and Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26 (2006) 1098-1106
40. Everall I., Salaria S., Roberts E., Corbeil J., Sasik R., Fox H., Grant I., and Masliah E. Methamphetamine stimulates interferon inducible genes in HIV infected brain. J. Neuroimmunol. 170 (2005) 158-171
41. Everall I., Vaida F., Khanlou N., Lazzaretto D., Achim C., Letendre S., Moore D., Ellis R., Cherne M., Gelman B., et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J. Neurovirol. (2009) 10.1080/13550280903131915 in press. Published online September 8, 2009
42. Fischer-Smith T., Bell C., Croul S., Lewis M., and Rappaport J. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman priomate studies. J. Neurovirol. 14 (2008) 318-326
43. Fox H.S. Virus-host interaction in the simian immunodeficiency virus-infected brain. J. Neurovirol. 14 (2008) 286-291
44. Gelman B.B., and Schuenke K. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J. Neurovirol. 10 (2004) 98-108
45. Gelman B.B., and Nguyen T.P. Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: Proteomic analysis of human synaptosomes. J. Neuroimmune Pharmacol. (2009) 10.1007/s11481-009-9168-0 in press. Published online August 19, 2009
46. Gendelman H.E. Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders. J. Neuroimmune Pharmacol. 2 (2007) 8-13
47. Gendelman H.E., Narayan O., Molineaux S., Clements J.E., and Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc. Natl. Acad. Sci. USA 82 (1985) 7086-7090
48. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G., Ghorbi Z., Clements J.E., Stanley J., and Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 58 (1986) 67-74
49. Gendelman H.E., Lipton S.A., Tardieu M., Bukrinsky M.I., and Nottet H.S. The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 56 (1994) 389-398
50. Gendelman H.E., Zheng J., Coulter C.L., Ghorpade A., Che M., Thylin M., Rubocki R., Persidsky Y., Hahn F., Reinhard Jr. J., and Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178 (1998) 1000-1007
51. Gendelman H.E., Kabanov A., and Linder J. The promise and perils of CNS drug delivery: a video debate. J. Neuroimmune Pharmacol. 3 (2008) 58
52. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5 (2005) 69-81
53. Gorantla S., Liu J., Sneller H., Dou H., Holguin A., Smith L., Ikezu T., Volsky D.J., Poluektova L., and Gendelman H.E. Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J. Immunol. 179 (2007) 4345-4356
54. Gorantla S., Sneller H., Walters L., Sharp J.G., Pirruccello S.J., West J.T., Wood C., Dewhurst S., Gendelman H.E., and Poluektova L. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J. Virol. 81 (2007) 2700-2712
55. Gorantla S., Liu J., Wang T., Holguin A., Sneller H.M., Dou H., Kipnis J., Poluektova L., and Gendelman H.E. Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 56 (2008) 223-232
56. Grant I. Neurocognitive disturbances in HIV. Int. Rev. Psychiatry 20 (2008) 33-47
57. Gray F., Bazille C., Adle-Biassette H., Mikol J., Moulignier A., and Scaravilli F. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J. Neurovirol. 11 Suppl 3 (2005) 16-22
58. Haase A.T. Pathogenesis of lentivirus infections. Nature 322 (1986) 130-136
59. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., and Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
60. Holden C.P., Haughey N.J., Nath A., and Geiger J.D. Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes. Neuroscience 91 (1999) 1369-1378
61. Huang X., Reynolds A.D., Mosley R.L., and Gendelman H.E. CD 4+ T cells in the pathobiology of neurodegenerative disorders. J. Neuroimmunol. 211 (2009) 3-15
62. Ikezu T. The aging of human-immunodeficiency-virus-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 4 (2009) 161-162
63. Jassoy C., Harrer T., Rosenthal T., Navia B.A., Worth J., Johnson R.P., and Walker B.D. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens. J. Virol. 67 (1993) 2844-2852
64. Ju S.M., Song H.Y., Lee J.A., Lee S.J., Choi S.Y., and Park J. Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp. Mol. Med. 41 (2009) 86-93
65. Kadiu I., Ricardo-Dukelow M., Ciborowski P., and Gendelman H.E. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J. Immunol. 178 (2007) 6404-6415
66. Kaul M., Zheng J., Okamoto S., Gendelman H.E., and Lipton S.A. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12 Suppl 1 (2005) 878-892
67. Kim W.K., Corey S., Chesney G., Knight H., Klumpp S., Wuthrich C., Letvin N., Koralnik I., Lackner A., Veasey R., and Williams K. Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus. J. Neurovirol. 10 (2004) 315-325
68. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., and Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
69. Kumar R., Orsoni S., Norman L., Verma A.S., Tirado G., Giavedoni L.D., Staprans S., Miller G.M., Buch S.J., and Kumar A. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 354 (2006) 192-206
70. Kumar A.M., Fernandez J., Singer E.J., Commins D., Waldrop-Valverde D., Ownby R.L., and Kumar M. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J. Neurovirol. (2009) 10.1080/13550280902973952 in press. Published online June 3, 2009
71. Langford D., Adame A., Grigorian A., Grant I., McCutchan J.A., Ellis R.J., Marcotte T.D., and Masliah E. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J. Acquir. Immune Defic. Syndr. 34 (2003) 467-474
72. Lee C., Tomkowicz B., Freedman B.D., and Collman R.G. HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways. J. Leukoc. Biol. 78 (2005) 1016-1023
73. Letendre S.L., McCutchan J.A., Childers M.E., Woods S.P., Lazzaretto D., Heaton R.K., Grant I., and Ellis R.J. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann. Neurol. 56 (2004) 416-423
74. Letendre S.L., Woods S.P., Ellis R.J., Atkinson J.H., Masliah E., van den Brande G., Durelle J., Grant I., and Everall I. Lithium improves HIV-associated neurocognitive impairment. AIDS 20 (2006) 1885-1888
75. Letendre S., Paulino A.D., Rockenstein E., Adame A., Crews L., Cherner M., Heaton R., Ellis R., Everall I.P., Grant I., and Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J. Infect. Dis. 196 (2007) 361-370
76. Letendre S., Marquie-Beck J., Capparelli E., Best B., Clifford D., Collier A.C., Gelman B.B., McArthur J.C., McCutchan J.A., Morgello S., et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol. 65 (2008) 65-70
77. Li J., Bentsman G., Potash M.J., and Volsky D.J. Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infection. BMC Neurosci. 8 (2007) 31
78. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., and Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15 (2009) 192-199
79. Liu J., Johnson T.V., Lin J., Ramirez S.H., Bronich T.K., Caplan S., Persidsky Y., Gendelman H.E., and Kipnis J. T cell independent mechanism for copolymer-1-induced neuroprotection. Eur. J. Immunol. 37 (2007) 3143-3154
80. Liu J., Gong N., Huang X., Reynolds A.D., Mosley R.L., and Gendelman H.E. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J. Immunol. 182 (2009) 3855-3865
81. Maiuri M.C., Zalckvar E., Kimchi A., and Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Neurosci. 8 (2007) 741-752
82. Mantovani S., Garbelli S., Pasini A., Alimonti D., Perotti C., Melazzini M., Bendotti C., and Mora G. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 210 (2009) 73-79
83. Marcondes M.C., Burdo T.H., Sopper S., Huitron-Resendiz S., Lanigan C., Watry D., Flynn C., Zandonatti M., and Fox H.S. Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virus-infected monkeys is associated with a unique cytokine environment. J. Immunol. 178 (2007) 5812-5819
84. Marcondes M.C., Burudi E.M., Huitron-Resendiz S., Sanchez-Alavez M., Watry D., Zandonatti M., Henriksen S.J., and Fox H.S. Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J. Immunol. 167 (2001) 5429-5438
85. Marcondes M.C., Flynn C., Huitron-Rezendiz S., Watry D.D., Zandonatti M., and Fox H.S. Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys. AIDS 23 (2009) 1187-1195
86. Marra C.M., Zhao Y., Clifford D.B., Letendre S., Evans S., Henry K., Ellis R.J., Rodriguez B., Coombs R.W., Schifitto G., et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23 (2009) 1359-1366
87. McArthur J.C., Brew B.J., and Nath A. Neurological complications of HIV infection. Lancet Neurol. 4 (2005) 543-555
88. McCrossan M., Marsden M., Carnie F.W., Minnis S., Hansoti B., Anthony I.C., Brettle R.P., Bell J.E., and Simmonds P. An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 129 (2006) 503-516
89. Meisner F., Scheller C., Kneitz S., Sopper S., Neuen-Jacob E., Riederer P., ter Meulen V., and Koutsilieri E. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33 (2008) 2228-2236
90. Nath A., Haughey N.J., Jones M., Anderson C., Bell J.E., and Geiger J.D. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47 (2000) 186-194
91. Nath A., Schiess N., Venkatesan A., Rumbaugh J., Sacktor N., and McArthur J. Evolution of HIV dementia with HIV infection. Int. Rev. Psychiatry 20 (2008) 25-31
92. Neuenburg J.K., Cho T.A., Nilsson A., Bredt B.M., Hebert S.J., Grant R.M., and Price R.W. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J. Acquir. Immune Defic. Syndr. 39 (2005) 16-22
93. Nowacek A., and Gendelman H.E. NanoART, neuroAIDS and CNS drug delivery. Nanomed 4 (2009) 557-574
94. Okamoto S., Kang Y.J., Brechtel C.W., Siviglia E., Russo R., Clemente A., Harrop A., McKercher S., Kaul M., and Lipton S.A. HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 1 (2007) 230-236
95. Pendyala G., Trauger S.A., Kalisiak E., Ellis R.J., Siuzdak G., and Fox H.S. Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J. Proteome Res. 8 (2009) 2253-2260
96. Peng H., Erdmann N., Whitney N., Dou H., Gorantla S., Gendelman H.E., Ghorpade A., and Zheng J. HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia 54 (2006) 619-629
97. Peng F., Dhillon N., Callen S., Yao H., Bokhari S., Zhu X., Baydoun H.H., and Buch S. Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J. Neurovirol. 14 (2008) 62-72
98. Peng F., Dhillon N.K., Yao H., Zhu X., Williams R., and Buch S. Mechanisms of platelet-derived growth factor-mediated neuroprotection-implications in HIV dementia. Eur. J. Neurosci. 28 (2008) 1255-1264
99. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 1 (2006) 223-236
100. Peterson P.K., Sharp B.M., Gekker G., Portoghese P.S., Sannerud K., and Balfour Jr. H.H. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 4 (1990) 869-873
101. Petito C.K., Adkins B., McCarthy M., Roberts B., and Khamis I. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J. Neurovirol. 9 (2003) 36-44
102. Petito C.K., Torres-Munoz J.E., Zielger F., and McCarthy M. Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J. Neurovirol. 12 (2006) 272-283
103. Pettoello-Mantovani M., Kollmann T.R., Katopodis N.F., Raker C., Kim A., Yurasov S., Wiltshire H., and Goldstein H. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. J. Infect. Dis. 177 (1998) 337-346
104. Rallon N.I., Lopez M., Soriano V., Garcia-Samaniego J., Romero M., Labarga P., Garcia-Gasco P., Gonzalez-Lahoz J., and Benito J.M. Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin. Exp. Immunol. 155 (2009) 35-43
105. Reynolds A.D., Banerjee R., Liu J., Gendelman H.E., and Mosley R.L. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. J. Leukoc. Biol. 82 (2007) 1083-1094
106. Reynolds A.D., Stone D.K., Mosley R.L., and Gendelman H.E. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J. Immunol. 182 (2009) 4137-4149
107. Reynolds A.D., Stone D.K., Mosley R.L., and Gendelman H.E. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. J. Proteome Res. 8 (2009) 3497-3511
108. Ricardo-Dukelow M., Kadiu I., Rozek W., Schlautman J., Persidsky Y., Ciborowski P., Kanmogne G.D., and Gendelman H.E. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J. Neuroimmunol. 185 (2007) 37-46
109. Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J., Gonzalez R., Wolfson T., and Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J. Int. Neuropsychol. Soc. 10 (2004) 1-14
110. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A., and Fox H.S. Induction of pathogenic sets of genes in macrophages and neurons in neuroAIDS. Am. J. Pathol. 162 (2003) 2041-2057
111. Roberts E.S., Huitron-Resendiz S., Taffe M.A., Marcondes M.C., Flynn C.T., Lanigan C.M., Hammond J.A., Head S.R., Henriksen S.J., and Fox H.S. Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J. Neurosci. 26 (2006) 4577-4585
112. Robertson D.R., and Hall C.D. Assessment of neuroAIDS in the international setting. J. Neuroimmune Pharm. 2 (2007) 105-111
113. Roth M.D., Tashkin D.P., Choi R., Jamieson B.D., Zack J.A., and Baldwin G.C. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J. Infect. Dis. 185 (2002) 701-705
114. Roy S., Charboneau R.G., Barke R.A., and Loh H.H. Role of mu-opioid receptor in immune function. Adv. Exp. Med. Biol. 493 (2001) 117-126
115. Roy S., Wang J., Kelschenbach J., Koodie L., and Martin J. Modulation of immune function by morphine: implications for susceptibility to infection. J. Neuroimmune Pharmacol. 1 (2006) 77-89
116. Rozek W., Ricardo-Dukelow M., Holloway S., Gendelman H.E., Wojna V., Melendez L.M., and Ciborowski P. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J. Proteome Res. 6 (2007) 4189-4199
117. Saas P., Walker P.R., Quiquerez A.L., Chalmers D.E., Arrighi J.F., Lienard A., Boucraut J., and Dietrich P.Y. A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport 13 (2002) 1921-1924
118. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8 Suppl 2 (2002) 115-121
119. Sadagopal S., Lorey S.L., Barnett L., Basham R., Lebo L., Erdem H., Haman K., Avison M., Waddell K., Haas D.W., and Kalams S.A. Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J. Virol. 82 (2008) 10418-10428
120. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 (2000) 455-458
121. Sarkar S., Floto R.A., Berger Z., Imarisio S., Cordenier A., Pasco M., Cook L.J., and Rubinsztein D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170 (2005) 1101-1111
122. Schifitto G., Peterson D.R., Zhong J., Ni H., Cruttenden K., Gaugh M., Gendelman H.E., Boska M., and Gelbard H. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 66 (2006) 919-921
123. Schifitto G., Navia B.A., Yiannoutsos C.T., Marra C.M., Chang L., Ernst T., Jarvik J.G., Miller E.N., Singer E.J., Ellis R.J., et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21 (2007) 1877-1886
124. Schifitto G., Zhong J., Gill D., Peterson D.R., Gaugh M.D., Zhu T., Tivarus M., Cruttenden K., Maggirwar S.B., Gendelman H.E., et al. Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. J. Neurovirol. 15 (2009) 176-186
125. Speth C., Schabetsberger T., Mohsenipour I., Stockl G., Wurzner R., Stoiber H., Lass-Florl C., and Dierich M.P. Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J. Virol. 76 (2002) 3179-3188
126. Spitzenberger T.J., Heilman D., Diekmann C., Batrakova E.V., Kabanov A.V., Gendelman H.E., Elmquist W.F., and Persidsky Y. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J. Cereb. Blood Flow Metab. 27 (2007) 1033-1042
127. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 131 (2007) 1164-1178
128. Strijbos P.J., and Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15 (1995) 3468-3474
129. Terzieva V., Popova D., Kicheva M., Todorova Y., Markova R., Martinova F., Elenkov I., and Yankova M. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. Int. Immunopharmacol. 9 (2009) 831-836
130. Tomlinson G.S., Simmonds P., Busuttil A., Chiswick A., and Bell J.E. Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol. Appl. Neurobiol. 25 (1999) 369-379
131. Turchan-Cholewo J., Liu Y., Gartner S., Reid R., Jie C., Peng X., Chen K.C., Chauhan A., Haughey N., Cutler R., et al. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiol. Dis. 23 (2006) 109-119
132. Valcour V., Shikuma C., Shiramizu B., Watters M., Poff P., Selnes O., Holck P., Grove J., and Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63 (2004) 822-827
133. Valcour V., Watters M.R., Williams A.E., Sacktor N., McMurtray A., and Shikuma C. Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J. Neurovirol. 14 (2008) 362-367
134. Venkataramana A., Pardo C.A., McArthur J.C., Kerr D.A., Irani D.N., Griffin J.W., Burger P., Reich D.S., Calabresi P.A., and Nath A. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67 (2006) 383-388
135. Wang T., Gong N., Liu J., Kadiu I., Kraft-Terry S.D., Mosley R.L., Volsky D.J., Ciborowski P., and Gendelman H.E. Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS ONE 3 (2008) e2507
136. Wang T., Gong N., Liu J., Kadiu I., Kraft-Terry S.D., Schlautman J.D., Ciborowski P., Volsky D.J., and Gendelman H.E. HIV-1-infected astrocytes and the microglial proteome. J. Neuroimmune Pharmacol. 3 (2008) 173-186
137. Wege A.K., Melkus M.W., Denton P.W., Estes J.D., and Garcia J.V. Functional and phenotypic characterization of the humanized BLT mouse model. Curr. Top. Microbiol. Immunol. 324 (2008) 149-165
138. Williams R., Bokhari S., Silverstein P., Pinson D., Kumar A., and Buch S. Nonhuman primate models of NeuroAIDS. J. Neurovirol. 14 (2008) 292-300
139. Williams R., Dhillon N.K., Hegde S.T., Yao H., Peng F., Callen S., Chebloune Y., Davis R.L., and Buch S.J. Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 57 (2009) 734-743
140. Woods S.P., Moore D.J., Weber E., and Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol. Rev. 19 (2009) 152-168
141. Xing H.Q., Hayakawa H., Izumo K., Kubota R., Gelpi E., Budka H., and Izumo S. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 29 (2009) 433-442
142. Yadav A., and Collman R.G. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. (2009) 10.1007/s11481-009-9174-2 in press. Published online September 18, 2009
143. Zhang L., Looney D., Taub D., Chang S.L., Way D., Witte M.H., Graves M.C., and Fiala M. Cocaine opens the blood-brain barrier to HIV-1 invasion. J. Neurovirol. 4 (1998) 619-626
144. Zheng J., and Gendelman H.E. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10 (1997) 319-325
145. Zheng J.C., Huang Y., Tang K., Cui M., Niemann D., Lopez A., Morgello S., and Chen S. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J. Neuroimmunol. 200 (2008) 100-110
146. Zhu Y., Vergote D., Pardo C., Noorbakhsh F., McArthur J.C., Hollenberg M.D., Overall C.M., and Power C. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J. 23 (2009) 2928-2941
147. Zink M.C., Uhrlaub J., DeWitt J., Voelker T., Bullock B., Mankowski J., Tarwater P., Clements J., and Barber S. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293 (2005) 2003-2011